Citigroup
WHWK

Citigroup’s Whitehawk Therapeutics WHWK Stock Holding History

Citigroup’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.8K Buy
15,019
+8,860
+144% +$36.9K ﹤0.01% 4869
2026
Q1 		$21.2K Buy
+6,159
New +$19.3K ﹤0.01% 4805
2025
Q2 		– Sell
-75
Closed -$134 – 5965
2025
Q1 		$134 Hold
75
– – ﹤0.01% 5429
2024
Q4 		$237 Sell
75
-6
-7% -$14 ﹤0.01% 5656
2024
Q3 		$167 Sell
81
-2,676
-97% -$4.33K ﹤0.01% 5520
2024
Q2 		$4.03K Sell
2,757
-840
-23% -$1.56K ﹤0.01% 5277
2024
Q1 		$8.42K Buy
3,597
+1,275
+55% +$2.46K ﹤0.01% 5240
2023
Q4 		$4.69K Buy
2,322
+1,904
+456% +$7.99K ﹤0.01% 5342
2023
Q3 		$2.02K Sell
418
-4,419
-91% -$25.7K ﹤0.01% 4952
2023
Q2 		$33.1K Buy
4,837
+4,836
+483,600% +$37.6K ﹤0.01% 4823
2023
Q1 		$7 Sell
1
-98
-99% -$1.05K ﹤0.01% 5417
2022
Q4 		$1.27K Sell
99
-121
-55% -$1.58K ﹤0.01% 5358
2022
Q3 		$3K Sell
220
-17,469
-99% -$230K ﹤0.01% 5431
2022
Q2 		$218K Sell
17,689
-8,300
-32% -$123K ﹤0.01% 3805
2022
Q1 		$441K Sell
25,989
-10,177
-28% -$195K ﹤0.01% 3601
2021
Q4 		$873K Buy
36,166
+35,518
+5,481% +$892K ﹤0.01% 3386
2021
Q3 		$19K Buy
+648
New +$19.8K ﹤0.01% 5260
2019
Q1 		– Sell
-16,131
Closed -$411K – 7846
2018
Q4 		$411K Buy
+16,131
New +$514K ﹤0.01% 4341

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citigroup's WHWK Position: Q2 2026 in Review

Citigroup increased its Whitehawk Therapeutics (WHWK) stake by 144% in Q2 2026, buying an estimated $36.9K and bringing the position to 15,019 shares worth $68.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4869.

Citigroup first reported a position in WHWK in Q4 2018 and has held it in 18 quarters since. The position peaked at $873K in Q4 2021. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Citigroup held 15,019 shares of Whitehawk Therapeutics worth $68.8K as of Q2 2026.
  • Citigroup bought 8,860 Whitehawk Therapeutics shares in Q2 2026, an estimated $36.9K.
  • Whitehawk Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4869 holding.
  • Citigroup first reported a position in Whitehawk Therapeutics in Q4 2018 and has held it in 18 quarters since.
  • Citigroup's Whitehawk Therapeutics position peaked at $873K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.